From unexplained COPD to an Alpha-1 answer
A family story about early emphysema, genetic testing for COPD, and finding community after an AATD diagnosis.
By MEF Editorial Team · Monday, July 20, 2026
For years, the cough and shortness of breath were blamed on "ordinary COPD." The smoking history did not fully match the severity. A relative's early emphysema finally pushed the care team to order Alpha-1 testing.
The turning point
A serum Alpha-1 Antitrypsin level came back low. Genotyping confirmed a deficiency genotype. Suddenly the family had a name for what had felt like a string of unlucky lung findings: Alpha-1 Antitrypsin Deficiency (AATD).
If that arc sounds familiar, start with genetic testing for COPD, our COPD and emphysema pages, and the educational self-check.
What helped after diagnosis
- A pulmonologist who explained results without blame.
- Clear reading on symptoms and medications and treatments.
- Peer stories on living with Alpha-1 and community events.
Research and honesty
Families often ask what is proven today versus what is still being studied. The foundation keeps established AATD lung and liver education separate from research hypotheses about broader disease connections. That honesty matters when you are making care decisions.
You are not alone
Browse more stories, explore newly diagnosed resources, or support the mission so the next family finds answers sooner.